Similar to This
Previous
Novo Nordisk: Profit Hammer! But the Number Showcase Has a Catch: The Wegovy pill is booming, Novo Nordisk raises its forecast again. But the quarterly report ...
wallstreet-online.de/nachricht/21634779-aktie-haussiert-novo-nordisk-gewinn-hammer-zahlenfeuerwerk-haken

Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs: Novo stock popped early Wednesday on better-than-expected third-quarter sales and ...
investors.com/news/technology/novo-stock-novo-earnings-q3-2026/

Novo Nordisk lifts 2026 outlook as Wegovy pill surges: Weight-loss pill sales surge 53% in third quarter, beating analyst forecasts
timeslive.co.za/news/world/2026-11-04-novo-nordisk-lifts-2026-outlook-as-wegovy-pill-surges/
Zepbound grew 174.9% in 2025, the fastest rate among the top 10 drugs: Seven of the best-selling drugs of 2026 from GEN's top 10, ranked by 2025 sales ...
qz.com/best-selling-drugs-2026-2025-sales

Lilly's next-gen weight loss drug more than doubled Novo Nordisk's in trial: Retatrutide lowered A1C, a blood sugar measure, by 2.2% versus 1.8% for Ozempic ...
qz.com/lilly-retatrutide-ozempic-weight-loss-trial-102826

Eli Lilly shoots to a new record high according to figures - | and leaves Novo in the dust
deraktionaer.de/artikel/pharma-biotech/eli-lilly-schiesst-nach-zahlen-auf-ein-neues-rekordhoch-und-zeigt-novo-die-ruecklichter-20428193.html

Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top Pick
seekingalpha.com/article/4958217-novo-nordisk-vs-eli-lilly-q3-preview-id-now-buy-both-but-lilly-is-my-top-pick

Paid articlePaywallLilly is worth 6 times as much as Novo: Will the gap now widen even further?: Novo Nordisk fails with an emergency application against Lilly's advertising ...
wallstreet-online.de/nachricht/21588504-klatsche-gericht-lilly-6-mal-wert-novo-abstand-groesser

US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk
reuters.com/world/us-judge-lets-eli-lilly-continue-ads-weight-loss-drugs-rules-against-novo-2026-10-26/

DAX falls - | Novo Nordisk, Meta, Nvidia, Porsche, Beiersdorf, Apple, Eli Lilly, Cancom
boerse-online.de/nachrichten/aktien/dax-faellt-novo-nordisk-meta-nvidia-porsche-beiersdorf-apple-eli-lilly-cancom-20425362.html

Weight-loss medications: Eli Lilly soaring, Novo Nordisk in freefall: Novo Nordisk expects a sales decline of up to 6 percent. Competitor Eli Lilly ...
manager-magazin.de/unternehmen/pharma/eli-lilly-us-konzern-im-hoehenflug-novo-nordisk-rechnet-mit-rueckgaengen-a-839421a1-543a-49a2-aec1-d4b8f1e13d41

Novo Nordisk: Forecast up, but...: Novo Nordisk raises its sales forecast due to the success of the Wegovy weight-loss pill and now expects a decline of no more ...
deraktionaer.de/artikel/aktien/novo-nordisk-prognose-rauf-aber-20406085.html

Obesity battle heats up again as Novo claws way back into race with Lilly: Novo Nordisk investors have found little cause for optimism during a bruising two-year ...
reuters.com/legal/litigation/obesity-battle-heats-up-again-novo-claws-way-back-into-race-with-lilly-2026-08-03/

Novo Nordisk beats earnings expectations and the stock surges on demand for weight loss pill
qz.com/novo-nordisk-q1-2026-earnings-wegovy-pill-guidance-050626

Novo Nordisk stock under pressure: Competition, IPO, pill race, billion-dollar deal: How the situation is changing for Novo Nordisk
finanzen.net/nachricht/aktien/adipositas-markt-novo-nordisk-aktie-unter-druck-wettbewerb-verschaerft-sich-neue-rivalen-neue-pillen-00-15620444

In Novo Nordisk's slipstream: Danish pharmaceutical IPO ahead?: Danish pharmaceutical company LEO Pharma is apparently planning an IPO with a focus on skin ...
deraktionaer.de/artikel/pharma-biotech/im-windschatten-von-novo-nordisk-daenisches-pharma-ipo-voraus-20397245.html

Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
cnbc.com/2026/02/04/eli-lilly-novo-nordisk-earnings-glp1-market.html

Novo Nordisk predicts "shocking" revenue decline - | Shares plummet: Competition in the weight-loss drug market is intensifying for the Danish company ...
faz.net/aktuell/wirtschaft/unternehmen/novo-nordisk-sagt-schockierenden-umsatzrueckgang-voraus-aktie-rauscht-ab-110831297.html

Novo Nordisk: Investors hesitant - | important date ahead: Novo Nordisk share stabilizes, analysts skeptical ahead of Q4 report on Feb 4; focus on Wegovy.
deraktionaer.de/artikel/deraktionaerplus/novo-nordisk-anleger-zoegern-wichtiger-termin-voraus-20393910.html

Novo Nordisk: Advantage over Eli Lilly - | chart breakout ahead?: Novo Nordisk's new weight-loss pill on the US market, CEO sees advantages over injectable ...
deraktionaer.de/artikel/deraktionaerplus/novo-nordisk-vorteil-gegenueber-eli-lilly-charttechnischer-ausbruch-voraus-20393398.html

Paid articlePaywall Next
